| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.7M | +25.5% |
| Cost of Revenue | $31.2M | +25.4% |
| Gross Profit | $10.5M | +25.7% |
| R&D Expense | $16.8M | -9.7% |
| SG&A Expense | $51.9M | +53.1% |
| Operating Income | -$58.2M | -31.1% |
| Pre-tax Income | -$57.0M | -17.6% |
| Income Tax | $2K | +0.0% |
| Net Income | -$57.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -79.1% |
| Short-term Investments | $73.8M | — |
| Accounts Receivable | $5.8M | +130.4% |
| Inventory | $15.5M | +89.7% |
| Current Assets | $121.1M | +22.5% |
| Total Assets | $137.3M | +18.9% |
| Current Liabilities | $16.7M | +14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.1M | -25.6% |
| Capital Expenditures | $1.4M | +112.5% |
| Investing Cash Flow | -$74.4M | -3672.4% |
| Financing Cash Flow | $68.5M | -17.9% |
| Free Cash Flow | -$62.4M | -26.8% |
| -17.6% |
| EPS (Basic) | -$1.27 | +85.1% |
| EPS (Diluted) | -$1.27 | +85.1% |
| Long-term Debt |
| $40.0M |
| +33.3% |
| Total Liabilities | $55.3M | +27.4% |
| Stockholders' Equity | $82.0M | +13.7% |